Genotropin (somatropin) / Pfizer |
2012-000432-26: Prospective study on the metabolic and linear growth effects of growh hormone treatment in children with Kabuki Syndrome Verkennende studie naar de stofwisseling en groei-effecten van groeihormoon behandeling bij kinderen met Kabuki syndroom |
|
|
| Ongoing | 4 | 20 | Europe | Genotropin, Genotropin, Genotropin | Maastricht University Medical Centre, Pfizer | Kabuki Syndrome (KS, OMIM 147920) with a mutation in MLL2 gene. Kabuki Syndroom (KS, OMIM 147920) met een mutatie in MLL2 gen. | | | | |
2011-001313-14: Young adult Prader-Willi Study Effects of Growth Hormone after final height: A clinical care study to the optimal dosage of growth hormone in young adults with PWS. Jong volwassenen Prader Willy studie Effecten van groeihormoon nadat de eindlengte bereikt is: Een klinische studie naar de optimale dosering groeihormoon in jong volwassenen met PWS. |
|
|
| Ongoing | 3 | 20 | Europe | Genotropin, GENOTROPIN (Somatropin) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference is that GENOTROPIN is man-made., GENOTROPIN (Somatropin) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference is that GENOTROPIN is man-made. | Dutch growth research foundation, Pfizer | Prader Willi Syndrome | | | | |
2018-000918-38: STUDY ASSESSING SUBJECT PERCEPTION OF TREATMENT BURDEN WITH USE OF WEEKLY GROWTH HORMONE (SOMATROGON) VERSUS DAILY GROWTH HORMONE (GENOTROPIN®) INJECTIONS IN CHILDREN WITH GROWTH HORMONE DEFICIENCY |
|
|
| Not yet recruiting | 3 | 90 | Europe | Somatrogon, Genotropin, PF-06836922, Solution for injection, Powder and solvent for solution for injection, Genotropin, Genotropin GoQuick | Pfizer Inc., Pfizer Inc. | Growth Hormone Deficiency in Children, Treatment of children with growth failure due to growth hormone deficiency, Diseases [C] - Hormonal diseases [C19] | | | | |
NCT04697381: Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS |
|
|
| Completed | 3 | 33 | Japan | somatropin - GH naïve pediatric cohort, somatropin - GH treated cohort, somatropin - adult cohort | Pfizer | Prader-Willi Syndrome | 12/22 | 04/24 | | |
2024-000101-32: Study of the efficacy and safety of somatropin in Japanese participants with PWS |
|
|
| Not yet recruiting | 3 | 33 | Japan | Genotropin GoQuick, Powder and solvent for solution for injection, Genotropin | Pfizer, Inc., Pfizer, Inc. | Prader-Willi Syndrome, Prader-Willi Syndrome (PWS), Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] | | | | |
NCT03038594: Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients |
|
|
| Completed | 2/3 | 13 | US | Somatropin, Genotropin, Growth Hormone (GH), 0.09% Saline Solution, Placebo, Control | The University of Texas Medical Branch, Galveston, United States Department of Defense, Pfizer | Burns, Growth Hormone Treatment | 11/21 | 11/21 | | |
| Not yet recruiting | N/A | 25 | Europe | Somatropin, Genotropin (5,0 mg/mL), Placebo | Erasmus Medical Center, Foundation for Prader-Willi Research, Prader-Willi Fonds | Prader-Willi Syndrome | 09/26 | 10/26 | | |